This brand name is authorized in United States. It is also authorized in Canada, Japan, Spain, UK.
The drug ROBAXIN contains one active pharmaceutical ingredient (API):
1
|
UNII
125OD7737X - METHOCARBAMOL
|
Methocarbamol is a centrally acting muscle relaxant. Its muscle relaxing action is the result of the inhibition of polysynaptic reflexes in the spinal marrow and subcortical centres. |
|
Below package inserts are available for further reading:
Document | Type | Information Source | |
---|---|---|---|
ROBAXIN Solution for injection | MPI, US: SPL/Old | FDA, National Drug Code (US) |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC Group | Classification | |
---|---|---|
M03BA03 | Methocarbamol | M Musculo-skeletal system → M03 Muscle relaxants → M03B Muscle relaxants, centrally acting agents → M03BA Carbamic acid esters |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
CA | Health Products and Food Branch | 01930990, 01932187 |
ES | Centro de información online de medicamentos de la AEMPS | 32899 |
GB | Medicines & Healthcare Products Regulatory Agency | 25954, 381664 |
JP | 医薬品医療機器総合機構 | 1225003D1031 |
US | FDA, National Drug Code | 0641-6103, 0641-6217, 52244-449, 80425-0020, 80425-0021 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.